Category icon
APSC Consensus Recommendations on High-risk Chronic Coronary Syndrome

Jack Wei Chieh Tan, Derek P Chew, David Brieger, et al

Category icon
APSC Consensus Recommendations on DOACs in Asian Patients with AF

Daniel TT Chong, Felicita Andreotti, Peter Verhamme, et al

Category icon
ACC 2021 Discussion: The ISCHEMIA Trial

Gregg Stone, Harriette Van Spall

Category icon
Pharmacotherapy in Stable CAD: The ISCHEMIA Trial

Jonathan Yap, Derek P Chew, Gregg Stone, et al

Category icon
2020 APSC Consensus Recommendations on P2Y12 Inhibitor Use

Jack WC Tan, Derek P Chew, Muhamad Ali SK Abdul Kader, et al

Category icon
Redefining the Standard for Atrial Fibrillation: A Patient-centric Report

Carina Blomström-Lundqvist, Helmut Pürerfellner, Alex White, et al

Category icon
DOACs in Chronic Coronary Syndromes

Emmanuel Sorbets, Philippe Gabriel Steg,

Category icon
Antithrombotic Therapy After TAVI

Leslie Marisol Lugo, Rafael Romaguera, Joan Antoni Gómez-Hospital, et al

Category icon
Antithrombotic Treatment After Coronary Intervention

Tamara García Camarero, José M de la Torre Hernández,

Related Articles

Articles

APSC Consensus Recommendations on High-risk Chronic Coronary Syndrome

Jack Wei Chieh Tan, Derek P Chew, David Brieger,

Published:

Citation: European Cardiology Review 2021;16:e26.

APSC Consensus Recommendations on DOACs in Asian Patients with AF

Daniel TT Chong, Felicita Andreotti, Peter Verhamme,

Published:

Citation: European Cardiology Review 2021;16:e23.

Pharmacotherapy in Stable CAD: The ISCHEMIA Trial

Jonathan Yap, Derek P Chew, Gregg Stone,

Published:

Citation: European Cardiology Review 2021;16:e04.

2020 APSC Consensus Recommendations on P2Y12 Inhibitor Use

Jack WC Tan, Derek P Chew, Muhamad Ali SK Abdul Kader,

Published:

Citation: European Cardiology Review 2021;16:e02.